Omega Healthcare Investors (NYSE:OHI) Given New $44.00 Price Target at Truist Financial

Key Points

• Truist Financial has raised the price target for Omega Healthcare Investors from $39.00 to $44.00, indicating a potential upside of 3.18% based on the stock's previous close.
• Despite a hold rating from Truist, the current consensus rating for the stock is "Moderate Buy," with a consensus price target of $43.38.
• Omega Healthcare's recent earnings report showed a significant beat on estimates, with earnings per share of $0.77 compared to the consensus of $0.45, along with a year-over-year revenue increase of 11.8%.

Omega Healthcare Investors (NYSE:OHI - Get Free Report) had its target price raised by equities research analysts at Truist Financial from $39.00 to $44.00 in a note issued to investors on Wednesday,Benzinga reports. The firm currently has a "hold" rating on the real estate investment trust's stock. Truist Financial's price target would indicate a potential upside of 3.18% from the stock's previous close.

A number of other research analysts have also recently weighed in on the stock. Raymond James Financial restated an "outperform" rating on shares of Omega Healthcare Investors in a research note on Tuesday. Royal Bank Of Canada lifted their price target on shares of Omega Healthcare Investors from $39.00 to $41.00 and gave the stock a "sector perform" rating in a research note on Thursday, August 7th. Scotiabank upped their price target on shares of Omega Healthcare Investors from $39.00 to $42.00 and gave the stock a "sector perform" rating in a research report on Thursday, August 28th. Finally, Wells Fargo & Company upped their price target on shares of Omega Healthcare Investors from $41.00 to $44.00 and gave the stock an "overweight" rating in a research report on Wednesday, August 27th. Five research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company's stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $43.38.

Omega Healthcare Investors Price Performance

Shares of NYSE OHI opened at $42.64 on Wednesday. Omega Healthcare Investors has a fifty-two week low of $35.04 and a fifty-two week high of $44.42. The company has a 50 day simple moving average of $39.27 and a two-hundred day simple moving average of $37.88. The company has a market capitalization of $12.58 billion, a price-to-earnings ratio of 26.32, a P/E/G ratio of 2.26 and a beta of 0.71. The company has a debt-to-equity ratio of 0.96, a quick ratio of 7.10 and a current ratio of 7.10.

Omega Healthcare Investors (NYSE:OHI - Get Free Report) last announced its earnings results on Thursday, July 31st. The real estate investment trust reported $0.77 earnings per share for the quarter, beating analysts' consensus estimates of $0.45 by $0.32. The business had revenue of $235.60 million during the quarter, compared to the consensus estimate of $248.49 million. Omega Healthcare Investors had a net margin of 42.23% and a return on equity of 9.78%. The business's revenue for the quarter was up 11.8% on a year-over-year basis. During the same quarter last year, the firm earned $0.71 earnings per share. Omega Healthcare Investors has set its FY 2025 guidance at 3.040-3.070 EPS. Analysts expect that Omega Healthcare Investors will post 2.86 EPS for the current fiscal year.

Insider Activity at Omega Healthcare Investors

In related news, Director Lisa Egbuonu-Davis sold 2,500 shares of the firm's stock in a transaction dated Friday, August 8th. The shares were sold at an average price of $40.16, for a total value of $100,400.00. Following the completion of the sale, the director owned 18,654 shares in the company, valued at $749,144.64. This trade represents a 11.82% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 1.50% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the business. Pathway Financial Advisers LLC increased its stake in Omega Healthcare Investors by 2.0% during the second quarter. Pathway Financial Advisers LLC now owns 91,715 shares of the real estate investment trust's stock valued at $3,361,000 after purchasing an additional 1,765 shares during the last quarter. Coppell Advisory Solutions LLC acquired a new position in Omega Healthcare Investors in the second quarter worth approximately $1,617,000. B. Riley Wealth Advisors Inc. acquired a new stake in shares of Omega Healthcare Investors in the second quarter worth $343,000. Advisory Services Network LLC increased its stake in shares of Omega Healthcare Investors by 2.6% in the second quarter. Advisory Services Network LLC now owns 53,326 shares of the real estate investment trust's stock valued at $2,074,000 after buying an additional 1,349 shares in the last quarter. Finally, Anchor Investment Management LLC increased its position in Omega Healthcare Investors by 23.1% in the second quarter. Anchor Investment Management LLC now owns 6,066 shares of the real estate investment trust's stock worth $222,000 after purchasing an additional 1,138 shares during the period. 65.25% of the stock is owned by institutional investors and hedge funds.

About Omega Healthcare Investors

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.